Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-29

Clinical Trial Update: Use of CGM in Kidney Transplant Recipients [NA]

View source ↗

Summary

A UC Davis-led clinical trial is evaluating the use of continuous glucose monitoring in kidney transplant recipients with type 2 diabetes; the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, Davis | Conditions: Kidney Transplant; Complications, Diabetes Mellitus, Type 2 | NA | Status: RECRUITING